NCT02174874View on ClinicalTrials.gov

Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)

CompletedOBSERVATIONAL
Enrollment

462

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2014

Conditions
Acute Gastroenteritis
Trial Locations (1)

T3B 6A8

Alberta Children's Hospital, Calgary

All Listed Sponsors
lead

Dr. Graham Thompson

OTHER

NCT02174874 - Ondansetron Oral Versus Orally Disintegrating Tablets (ODT) | Biotech Hunter | Biotech Hunter